Public Company News

Ascentage Pharma Presented at the 40th Annual J.P. Morgan Healthcare Conference Reporting Steady Transition Towards a Full-Fledged Biopharma

SUZHOU, China and ROCKVILLE, Md., Jan. 11, 2022 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that Dr.Dajun Yang, the company's Chairman and CEO...

2022-01-12 10:19 2900

ABL Bio Enters Global Collaboration and License Agreement with SANOFI to Advance ABL301 for the Treatment of Parkinson's Disease

* ABL and SANOFI to collaborate on the development of ABL301, a potential first-in-class bispecific antibody targeting alpha-synuclein and containing a proprietary brain shuttle, for alpha-synucleinopathies, including Parkinson's disease * ABL301 uses ABL's Grabody-B platform technology to ef...

2022-01-12 07:59 4078

CNFinance Holdings Limited Announces Board Changes

GUANGZHOU, China, Jan. 11, 2022 /PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider inChina, today announced the retirement of Mr. Paul Wolansky from the Board of Directors, effective onJanuary 11, 2022. Mr. Wolansky h...

2022-01-12 05:08 5047

Oliver Wyman acquires Azure Consulting, growing its presence in Australia

  The premium Perth-based boutique management consulting firm's 20 employees will be integrated intoOliver Wyman's Australia practice. The acquisition advancesOliver Wyman's build up in Australia and deepens its Energy and Natural Resources practice inAsia Pacific.   SYDNEY, Jan. 12, 2022 /PRN...

2022-01-12 04:00 7261

Terumo Medical Corporation Applauds ACC/AHA/SCAI Decision to Designate Radial Access Class 1, Level of Evidence A

SOMERSET, N.J., Jan. 11, 2022 /PRNewswire/ -- Terumo Medical Corporation (TMC) applauds the publication of updated guidelines from the American College of Cardiology (ACC), American Heart Association (AHA) and the Society for Cardiovascular Angiography and Interventions (SCAI) that give radial ac...

2022-01-12 03:40 2851

Japan-Insights from RENOSY Research: People became cautious about investment due to the pandemic with real estate receiving the most attention from investors

TOKYO, Jan. 11, 2022 /PRNewswire/ -- According to recent research released by "RENOSY", a one-stop comprehensive real estate service platform operated by GA technologies Co., Ltd (Headquarters: Minato-Ku,Tokyo; CEO: Ryo Higuchi / Securities Code: 3491) found more than 50% of the RENOSY users rese...

2022-01-12 01:00 2823

Infortrend EonStor CS NVMe SSD Storage Delivers High Throughput and Fast Response Time for Three Key Applications

TAIPEI, Jan. 11, 2022 /PRNewswire/ -- Infortrend® Technology, Inc.  (TWSE: 2495), the industry-leading enterprise storage provider, satisfies requirements of high throughput...

2022-01-11 23:00 2736

Senmiao Technology Announces Ride-Hailing Platform Operating Metrics for December 2021

CHENGDU, China, Jan. 11, 2022 /PRNewswire/ -- Senmiao Technology Limited ("Senmiao" or the "Company") (Nasdaq: AIHS), a financing and servicing company focused on the online ride-hailing industry inChina, as well as an operator of its own online ride-hailing platform, today announced the operatin...

2022-01-11 22:00 2255

Infobird Secures Contract for Digital Banking Solution with Changchun Rural Commercial Bank

BEIJING, Jan. 11, 2022 /PRNewswire/ -- Infobird Co., Ltd (Nasdaq: IFBD) ("Infobird" or the "Company"), a software-as-a-service provider of innovative AI-powered, or artificial intelligence-enabled, customer engagement solutions in China, announced that it has signed a contract with Changchun Rural...

2022-01-11 21:30 4343

IBM Acquires Envizi to Help Organizations Accelerate Sustainability Initiatives and Achieve Environmental Goals

ARMONK, N.Y., Jan. 11, 2022 /PRNewswire/ -- IBM (NYSE: IBM) today announced it has acquired Envizi, a leading data and analytics software provider for environmental performance management. This acquisition builds on IBM's growing investments in AI-powered software, including IBM Maximo asset mana...

2022-01-11 21:00 5034

First High-School Education Group Intends to Distribute Dividend

BEIJING, Jan. 11, 2022 /PRNewswire/ -- First High-School Education Group Co., Ltd. ("First High-School Education Group" or the "Company") (NYSE: FHS), an education service provider primarily focusing on high schools inWestern China, today announced its preliminary dividend distribution plan. Sub...

2022-01-11 20:30 4068

SOPHiA GENETICS Reports Strong Traction in the Launch Phase of its DEEP-Lung-IV Multimodal Clinical Study

BOSTON and LAUSANNE, Switzerland, Jan. 11, 2022 /PRNewswire/ -- SOPHiA GENETICS SA (NASDAQ: SOPH), the creator of a global data pooling and knowledge sharing platform that advances data-driven medicine, announced today strong traction in the launch phase of their DEEP-Lung-IV clinical study (NCT0...

2022-01-11 20:27 2344

Qilian International Holding Group Limited Releases 2022 Chairman Letter

JIUQUAN, China, Jan. 11, 2022 /PRNewswire/ -- Qilian International Holding Group Limited (Nasdaq: QLI) (the "Company", "Qilian International", "we", "our" or "us"), aChina-based pharmaceutical and chemical products manufacturer, today released a letter to shareholders from the Chairman of the Com...

2022-01-11 20:00 2381

Semiconductor Manufacturing International Corporation Fourth Quarter 2021 Webcast Conference Call

SHANGHAI, Jan. 11, 2022 /PRNewswire/ -- SMIC's fourth quarter 2021 results will be released on the Hong Kong Stock Exchange website (https://www.hkex.com.hk ) and Shanghai Stock Exchange website ( http://www.sse.com.cn ) after the close of trading ...

2022-01-11 18:39 6659

Smillage Provides One-Stop Game Publishing Service for Chinese Game Developers

SHANGHAI, Jan. 11, 2022 /PRNewswire/ -- Smillage, the game studio invested by CooTek (Cayman) Inc. (NYSE: CTK) ("CooTek" or the "Company"), has successively created popular games such as Catwalk Beauty, Truth Runner and Love Fantasy last year. The success of Hotties Up also represents a solid ste...

2022-01-11 17:00 2951

Aim Strong Growth in Business Results and Actively Deliver Returns to Shareholders

HONG KONG, Jan. 11, 2022 /PRNewswire/ -- CNOOC Limited (the "Company", SEHK: 00883) today announces a summary of its business strategy and development plan for the year 2022. The Company's targeted net production for 2022 is 600 million to 610 million barrels of oil equivalent (BOE), of which,...

2022-01-11 16:50 5063

Fosun Pharma and Insilico Medicine Announce a Strategic, AI-driven Drug Discovery and Development Collaboration to Jointly Advance Multiple Targets

SHANGHAI and NEW YORK, Jan. 11, 2022 /PRNewswire/ -- Shanghai Fosun Pharmaceutical (Group) Co., Ltd ("Fosun Pharma"; Stock Code: 600196.SH, 02196.HK), a leading innovation-driven international healthcare group inChina and Insilico Medicine ("Insilico"), an end-to-end artificial intelligence (AI)...

2022-01-11 16:30 4304

DL Holdings Appointed CEO Chen Ningdi as Chairman of the Board

HONG KONG, Jan. 11, 2022 /PRNewswire/ -- DL Holdings Group Limited ("DL Holdings" or the "Company" and its subsidiaries (together, the "Group"), Stock Code: 1709) announced on 10 January 2022 that Ms. Jiang Xinrong was re-designated from an executive Director and Chairman of the Board to a non-e...

2022-01-11 16:29 4674

Pixelworks Powers OnePlus 10 Pro Flagship to Deliver Superior Visual Experience

Showcases Always True-To-Life Color Appearance with Great Eye-Comfort Regardless ofAmbient Lighting Conditions SHANGHAI, Jan. 11, 2022 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ: PXLW), a leading provider of innovative video and display processing solutions, and OnePlus, a premium global smartphon...

2022-01-11 16:00 3474

Latest Study Shows Encouraging Results of CanSinoBIO's Inhaled COVID-19 Vaccine as Heterologous Booster

TIANJIN, China, Jan. 11, 2022 /PRNewswire/ -- CanSino Biologics Inc. ("CanSinoBIO") (SSE: 688185, HKEX: 06185) today announced thatPreprints with The Lancet, a collaboration between the research sharing platform SSRN and The Lancet, published a clinical study on the safety and immunogenicity of ...

2022-01-11 15:15 3194